---
title: "創維集團今早起停牌 涉併購及回購消息"
description: "創維集團股份已於今日 (5 日) 上午 9 時起短暫停止買賣，以待根據公司收購、合併及股份回購守則發出載有內幕消息之公告。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271447324.md"
published_at: "2026-01-05T01:42:24.000Z"
---

# 創維集團今早起停牌 涉併購及回購消息

> 創維集團股份已於今日 (5 日) 上午 9 時起短暫停止買賣，以待根據公司收購、合併及股份回購守則發出載有內幕消息之公告。

創維集團 (00751.HK) 股份已於今日 (5 日) 上午 9 時起短暫停止買賣，以待根據公司收購、合併及股份回購守則發出載有內幕消息之公告。

### Related Stocks

- [00751.HK - 創維集團](https://longbridge.com/zh-HK/quote/00751.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 00:16 ETSKYWORTH PV neemt deel aan Expo Greater Amsterdam met zijn SUN Mate-balkonzonnepaneeloplossing | SKYWORTH PV will participate in Expo Greater Amsterdam from March 10-12, 2026, showcasing its SUN Mate balcony solar pan | [Link](https://longbridge.com/zh-HK/news/275995515.md) |
| Skyworth Group Limited's (HKG:751) Top Key Executive Wang Wong is the most upbeat insider, and their holdings increased by 37% last week | Skyworth Group Limited's largest shareholder, Wang Wong, increased his holdings by 37% last week, reflecting significant | [Link](https://longbridge.com/zh-HK/news/273567949.md) |
| Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | [Link](https://longbridge.com/zh-HK/news/275882954.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/zh-HK/news/276016059.md) |
| China’s Lenovo warns of ‘prolonged’ memory crunch, looks to AI for rebound | Lenovo Group, the largest PC maker, reported a 21% profit drop due to a global memory crunch, warning of its prolonged i | [Link](https://longbridge.com/zh-HK/news/275760673.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。